Results 11 to 20 of about 7,683 (166)

Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. [PDF]

open access: yesPLoS ONE, 2014
BackgroundRifampicin and protease inhibitors are difficult to use concomitantly in patients with HIV-associated tuberculosis because of drug-drug interactions. Rifabutin has been proposed as an alternative rifamycin, but there is concern that the current
Nguyen Thi Ngoc Lan   +15 more
doaj   +2 more sources

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

open access: yesMemorias do Instituto Oswaldo Cruz, 2019
BACKGROUND Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART).
Carolina Arana Stanis Schmaltz   +3 more
doaj   +2 more sources

Rifabutin corneal deposits localized to the deep stroma using anterior segment optical coherence tomography [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To demonstrate that rifabutin-related corneal deposits are localized to the deep stroma using anterior segment optical coherence tomography (OCT) and confocal microscopy.
Tianyi Zhang   +3 more
doaj   +2 more sources

Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series

open access: yesAntibiotics, 2020
This is a case series of 10 patients who had staphylococcal biofilm infections that were treated with adjuvant rifabutin therapy instead of rifampin therapy.
James B. Doub   +4 more
doaj   +2 more sources

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure

open access: yesThe Korean Journal of Gastroenterology, 2017
Background/Aims: Optimized regimen has not yet been established for failures of multiple Helicobacter pylori (H. pylori) eradication. Hence, we aimed to evaluate the efficacy of rifabutin-based rescue therapy, at least after three eradication failures ...
Jihee Sung   +10 more
doaj   +2 more sources

Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin

open access: yesJournal of Primary Care & Community Health, 2023
Purpose: A case of a patient receiving warfarin for pulmonary embolism (PE) concomitantly with rifampin for treatment of active pulmonary tuberculosis (PTB) is presented.
Marwah E. Alnewais   +3 more
doaj   +2 more sources

A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects.

open access: yesPLoS ONE, 2019
Effects of steady-state rifabutin on the pharmacokinetics of steady-state maraviroc were investigated in fourteen healthy adult female and male volunteers. Maraviroc 300 mg twice daily (BID) was given orally with food for fifteen days.
M Ghannad   +9 more
doaj   +2 more sources

Segmental retinal arteritis in a case of presumed bilateral rifabutin-associated hypopyon uveitis

open access: yesAmerican Journal of Ophthalmology Case Reports
Purpose: To describe the presentation and clinical course of bilateral hypopyon uveitis and subsequently diagnosed segmental retinal arteritis in an immunocompromised patient treated with intravitreal and systemic antibiotics while on rifabutin therapy ...
Shefali Sood   +4 more
doaj   +2 more sources

Experimental study of the pharmacokinetics of rifabutin in liposomal form [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2013
On mongrel male rats studied pharmacokinetics of rifabutin in liposomal form, the relative bioavailability and tissue distribution after intratracheal administration, evaluated pharmacokinetic linearity.
M. V. Carlin   +6 more
doaj   +1 more source

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin [PDF]

open access: yesТонкие химические технологии, 2010
Properties of spherical amorphous nanoparticles loading with antituberculosis substance rifabutin are described. It was shown that rifabutin is loaded completely when content of the substance is 5% from the mass of carrier.
A. P. Kaplun   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy